Annual Securities Report — FY2025
What JCR Pharmaceuticals Co.,Ltd. reported for the period from 2025-04-01 to 2026-03-31.
Filed 2026-06-23View the original on EDINET
How much it says
69Detailed
What moved here
27named for the first time
Its own wording
59terms
Which filing this is
36/ 36newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
For the fiscal year under review, the Company recorded higher revenue and operating income, ordinary income and net income attributable to owners of the parent. The filing also describes R&D, including the acquisition of exclusive Japanese rights to Givinostat and progress across the pipeline, together with capital expenditure and financing for the new formulation plant and other facilities, including the commitment-line facility.
Komori's summary of this document, not the document's own words.69Detailed
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 35 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
68
Detailed
94
Very detailed
75
Very detailed
50
Typical
68
Detailed
37
Thin
100
Very detailed
60
Detailed
79
Very detailed
50
Typical
R&D spend168億円Money spent making new things.
Cash left over-183億円Cash from the business, less what went into equipment.
Spent on equipment107億円Plants, machines — things meant to last.
Employees985Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.